A Case of Angiosarcoma with Renal Failure Caused by Recombinant Interleukin-2 (rIL-2) and Non-steroid Anti-inflammatory Drug (NSAID)

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A 77-year-old man was diagnosed to have diabetes. He was hospitalized for appetite loss, weight loss (6 kg/3 months) and right femoral pain. An abnormal shadow was noted on chest X-P. On admission, he was alert and there were no abnormal physical findings except limitation in the range of motion in the right lower extremity. His femoral pain was treated by a non-steroid anti-inframmatory drug (NSAID). Right femoral bone biopsy revealed angiosarcoma and staining for factor VIII, with negative staining for epithelial membrane antigen on enzyme assay. Therefore, he received systemic administration of recombinant interleukin-2 (rIL-2). rIL-2 was administered intravenously twice daily at a dose of 40 X 104 JRU. The total dosage of rIL-2 amounted to 1200 X 104 JRU, but renal failure deteriorated and he died on the 50th hospital day of his second admission. Combination of rIL-2 and NSAID may cause progression of nephropathy. © 1995, The Japan Geriatrics Society. All rights reserved.

Cite

CITATION STYLE

APA

Shimizu, I., Fujii, Y., & Maeda, T. (1995). A Case of Angiosarcoma with Renal Failure Caused by Recombinant Interleukin-2 (rIL-2) and Non-steroid Anti-inflammatory Drug (NSAID). Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 32(2), 128–133. https://doi.org/10.3143/geriatrics.32.128

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free